GC Pharma

Sanfilippo,GC Pharma,Regulatory,Treatment,Regulatory

Breakthrough in Genetic Disorder Treatment: GC Pharma’s Sanfilippo Syndrome Drug Receives FDA Phase 1 Approval

SOUTH KOREA 5월 22, 2024 • 0 Comment
[su_heading size=”27″ align=”left” margin=”40″]Introduction to Sanfilippo Syndrome and GC Pharma’s Efforts[/su_heading] Sanfilippo Syndrome, also known as Mucopolysaccharidosis Type III, is…